FindTrial
Sign In

Gemcitabina Accord 200 mg concentrado para solución para perfusión

DRUG2 trials

Sponsors

Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas

Conditions

Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignant peripheral nerve sheath tumor) will receive selinexor in combination with gemcitabine.

Phase 1

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
WithdrawnCTIS2024-514827-40-00
Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En SarcomasPatients with advanced soft-tissue sarcoma (leiomyosarcoma or malignant peripheral nerve sheath tumor) will receive selinexor in combination with gemcitabine.
Target: 88Updated: 2024-08-02
Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
Not yet recruitingCTIS2024-520318-23-00
Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En SarcomasPatients with advanced soft-tissue sarcoma (leiomyosarcoma or malignant peripheral nerve sheath tumor) will receive selinexor in combination with gemcitabine.
Target: 88Updated: 2024-12-27